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Supplementary Table 1.  Data sources available to ROADMAP 
ROADMAP Level 1 – Consortium Partner Data Accessa 




Aarhus University Hospital database 2.3 million Hospital 
Copenhagen database 2.4 million Hospital 
France Memento 1,000 Memory clinic 
Netherlands 
IPCI 2 million Primary care 
Amsterdam dementia cohort 4,000 Memory clinic 
Parelsnoer clinical cohort 1,000 National memory clinic 
ACTIFCare cohort 400 Home living 
Learn cohort 300 Memory clinic 
Spain 
SIDIAP 5.8 million Primary care 
ReDeGi register 6,000 Hospital 
Sweden 
Gothenburg population study H70 8,200 Population cohorts 
Prospect Population Study of Women, 
in Gothenburg  1,467 Population cohorts 
SveDem 63,160 Population cohorts 
UK Cygnus care cohort 500 Memory clinic 
Multi-
country Clinical trial placebo data – Eli Lilly 2,000 Clinical trial data 
    
ROADMAP Level 2 + 3 – Consortium Partner Facilitated Accessa 
Country Data source 
Number of 
patients Setting 
Denmark National patient registers 5.6 million Administrative 
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Sweden 
LISA register 10 million Insurance data 
National patient registers 10 million Hospital 
QRegPV 10 million Primary care 
Social services register 10 million Administrative 
Tax agency register 10 million Administrative 
National healthcare register 10 million Administrative 
Military service register 7 million Administrative 
VEGA healthcare register 1.6 million Regional register 
UK 
NHS Digital 56 million Hospital 
eDRIS Scotland 5.7 million National linkage 
CPRD 5 million Primary care 
SAIL 3 million National linkage 
UK CRIS 3 million Mental health 
Dementias Platform UK, including:b 
 
    Million Women Study 










EMIF-AD 3,500 Population/patient cohorts 
EMIF EHR 40 million Primary care/hospital 
CAMD 6,500 Clinical trial placebo data 
aROADMAP had three levels of data access: 1. Direct access, where the data custodian 
was a ROADMAP consortium partner; 2. Accelerated/facilitated access, where a 
ROADMAP consortium partner was affiliated with, or an expert in access processes for, 
a data source; and 3. A standard application process for use by any research requestor. 
bThe remaining 200,000 patients are accounted for through other cohorts, some of 
which are not population cohorts but disease based. ACTIFCare, ACcess to Timely 
Formal Care; CAMD, Coalition Against Major Diseases; CPRD, Clinical Practice 
Research Datalink; CRIS, Clinical Record Interactive Search system; eDRIS, electronic 
Data Research and Innovation Service; EHR, electronic health record; EMIF-AD, 
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European Medical Information Framework-Alzheimer’s Disease project; IPCI, Integrated 
Primary Care Information database; LISA, Longitudinal integration database for health 
insurance and labour market studies; NHS, National Health Service; QRegPV, Primary 
care in the region of Västra Götaland register; ReDeGi, Registry of Dementias of 
Girona; SAIL, Secure Anonymised Information Linkage Databank; SIDIAP, Information 
System for Research in Primary Care; SveDem, Swedish Dementia Registry; VEGA, 
Western Swedish Health Care Register. 
 
